The agency approved the first over-the-counter continuous glucose monitor, known as Stelo, for adults with diabetes who do ...

Continuous glucose monitoring, compared with fingerstick tests, was feasible and accurate in an inpatient setting among patients and nurses.

The implementation of an inpatient continuous glucose monitoring policy was accurate ... The researchers also administered a System Usability Scale questionnaire to nurses who engaged with the ...

SENS' latest regulatory clearance is likely to simplify diabetes management with the help of a long-lasting CGM system.

Biosensors that measure glucose are now available without a prescription. Wearing one burst my wellness bubble in ways I wasn ...

Remote patient monitoring has exploded since the pandemic. In just four years from the beginning of 2019 through 2022, ...

With the company's market cap of $28 billion today, it's important to recognize that DexCom (NASDAQ: DXCM) is already one of ...

DexCom ( DXCM -2.62%) is not a stock that investors should be rushing to sell. It has a few different opportunities to ...

The FDA cleared Eversense 365 as the first 1-year integrated continuous glucose monitoring (CGM) system for adults with type ...

Little did I realize a few grapes could send my blood sugar soaring until I tried the first glucose monitor without a ...

Synex Medical just raised $21.8 million to build a portable MRI capable of testing glucose and other important molecules ...